Dr Llewellyn Mills

Division Addiction Medicine, Central Clinical School
South Eastern Sydney Local Health District, Drug and Alcohol Services

Telephone +61 421 032 614

Curriculum vitae Curriculum vitae

Map

Biographical details

I am a drug and alcohol researcher with the University of Sydney Medical School, working at the Langton Centre, a drug and alcohol treatment centre in Surry Hills.

The cost of addiction is enormous, for the individuals who suffer from it, their families, and society in general. I am committed to helping find new ways to treat addiction so that sufferers and their families can get closer to a normal, happy life. I have only just started on my research career but have already found the process of investigating addiction immensely rewarding, both the analytical side and the human side.

I cut my teeth testing caffeine withdrawal in heavy coffee drinkers. My doctoral thesis examined the ways that beliefs about how much of a drug we have in our body affect our perceptions of withdrawal symptoms via the placebo and nocebo effect. I found that when heavy coffee drinkers know their daily dose of caffeine has gone down it makes their withdrawal symptoms worse than if they are unaware it has gone down. I hope one day soon to test whether these findings can be used to tailor interventions to help treat people seeking drug and alcohol treatment.

Research interests

I am interested in:

1. The factors that cause and maintain addiction

2. The way that beliefs affect perceptions of withdrawal

3. The placebo and nocebo effect

4. Point of Care Trials

5. Longitudinal data analysis

6. Bayesian statistics

Teaching and supervision

Abnormal Psychology

Science and Statistics

Psychometrics and Individual Differences

Current projects

  • A randomised placebo-controlled trial of nabiximols for the treatment of cannabis dependence.
  • The Clinical Outcomes and Quality Indicators (COQI) Project
  • The Cannabis as Medicine Survey (CAMS)
  • Exercise and Cannabis Withdrawal - an RCT testing the effect of exercise on cannabis withdrawal
  • Cannabidiol for Treatment of Alcohol Withdrawal
  • MA Data - Using electronic clinical information systems to assess outcomes for people being treated for methamphetamine dependence
  • Updating and validating the cannabis withdrawal scale (CWS)

Associations

  • Division of Addiction Medicine, Faculty of Medicine and Public Health, University of Sydney
  • Drug and Alcohol Services, South Eastern Sydney Local Health District
  • School of Psychology, Univeristy of Sydney

Awards and honours

Travel Award, Society for Interdisciplinary Placebo Studies Conference (Leiden, The Netherlands, 2017)

Australian Postgraduate Award (2013-2016)

In the media

An article entitled Article Better Latte Than Never discussing my first study appeared in theWeekend Australian SupplementMagazine April 23-24, 2016

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Lintzeris, N., Bhardwaj, A., Mills, L., Dunlop, A., Copeland, J., McGregor, I., Bruno, R., Gugusheff, J., Phung, N., Montebello, M., Kirby, A., Allsop, D., et al (2019). Nabiximols for the Treatment of Cannabis Dependence A Randomized Clinical Trial. JAMA Internal Medicine. [More Information]
  • Mills, L., Boakes, R., Colagiuri, B. (2019). The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction. Journal of Psychopharmacology, 33(8), 994-1002. [More Information]
  • Meiser, B., Quinn, V., Mitchell, G., Tucker, K., Watts, K., Rahman, B., Peate, M., Saunders, C., Geelhoed, E., Gleeson, M., Barlow-Stewart, K., Bowen, M., Kirk, J., et al (2018). Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history. European Journal of Human Genetics, 26(7), 972-983. [More Information]
  • Mills, L., Dar-Nimrod, I., Colagiuri, B. (2017). Effect of Genetic Information and Information About Caffeine Content on Caffeine Withdrawal Symptoms. Scientific Reports, 7(1), 1-9. [More Information]
  • Norberg, M., Newins, A., Mills, L., Ham, L. (2017). Psychometric Validation of the Anticipated Effects of Alcohol Mixed With Energy Drinks Scale. Psychological Assessment, 29(12), 1505-1516. [More Information]
  • Mills, L., Boakes, R., Colagiuri, B. (2016). Placebo caffeine reduces withdrawal in abstinent coffee drinkers. Journal of Psychopharmacology, 30(4), 388-394. [More Information]

2019

  • Lintzeris, N., Bhardwaj, A., Mills, L., Dunlop, A., Copeland, J., McGregor, I., Bruno, R., Gugusheff, J., Phung, N., Montebello, M., Kirby, A., Allsop, D., et al (2019). Nabiximols for the Treatment of Cannabis Dependence A Randomized Clinical Trial. JAMA Internal Medicine. [More Information]
  • Mills, L., Boakes, R., Colagiuri, B. (2019). The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction. Journal of Psychopharmacology, 33(8), 994-1002. [More Information]

2018

  • Meiser, B., Quinn, V., Mitchell, G., Tucker, K., Watts, K., Rahman, B., Peate, M., Saunders, C., Geelhoed, E., Gleeson, M., Barlow-Stewart, K., Bowen, M., Kirk, J., et al (2018). Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history. European Journal of Human Genetics, 26(7), 972-983. [More Information]

2017

  • Mills, L., Dar-Nimrod, I., Colagiuri, B. (2017). Effect of Genetic Information and Information About Caffeine Content on Caffeine Withdrawal Symptoms. Scientific Reports, 7(1), 1-9. [More Information]
  • Norberg, M., Newins, A., Mills, L., Ham, L. (2017). Psychometric Validation of the Anticipated Effects of Alcohol Mixed With Energy Drinks Scale. Psychological Assessment, 29(12), 1505-1516. [More Information]

2016

  • Mills, L., Boakes, R., Colagiuri, B. (2016). Placebo caffeine reduces withdrawal in abstinent coffee drinkers. Journal of Psychopharmacology, 30(4), 388-394. [More Information]

To update your profile click here. For support on your academic profile contact .